| 000 | 01809 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250513200629.0 | ||
| 264 | 0 | _c20000303 | |
| 008 | 200003s 0 0 eng d | ||
| 022 | _a0022-1899 | ||
| 024 | 7 |
_a10.1086/315171 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aConnick, E | |
| 245 | 0 | 0 |
_aImmune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response. _h[electronic resource] |
| 260 |
_bThe Journal of infectious diseases _cJan 2000 |
||
| 300 |
_a358-63 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCD4 Lymphocyte Count |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aCandida _ximmunology |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHypersensitivity, Delayed |
| 650 | 0 | 4 |
_aImmune System _xdrug effects |
| 650 | 0 | 4 |
_aLamivudine _xtherapeutic use |
| 650 | 0 | 4 |
_aMumps virus _ximmunology |
| 650 | 0 | 4 |
_aRNA, Viral _xblood |
| 650 | 0 | 4 |
_aRitonavir _xtherapeutic use |
| 650 | 0 | 4 |
_aZidovudine _xtherapeutic use |
| 700 | 1 | _aLederman, M M | |
| 700 | 1 | _aKotzin, B L | |
| 700 | 1 | _aSpritzler, J | |
| 700 | 1 | _aKuritzkes, D R | |
| 700 | 1 | _aSt Clair, M | |
| 700 | 1 | _aSevin, A D | |
| 700 | 1 | _aFox, L | |
| 700 | 1 | _aChiozzi, M H | |
| 700 | 1 | _aLeonard, J M | |
| 700 | 1 | _aRousseau, F | |
| 700 | 1 | _aD'Arc Roe, J | |
| 700 | 1 | _aMartinez, A | |
| 700 | 1 | _aKessler, H | |
| 700 | 1 | _aLanday, A | |
| 773 | 0 |
_tThe Journal of infectious diseases _gvol. 181 _gno. 1 _gp. 358-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1086/315171 _zAvailable from publisher's website |
| 999 |
_c10564765 _d10564765 |
||